| Assay Method Information | |
| | Fluorescence Polarization Assay and FL5.12 Cellular Assay |
| Description: | The binding affinities (Ki) of compounds were determined using fluorescence polarization assays (FPA) that measure their ability to competitively displace a Bad-derived peptide from Bcl-xL. Compound efficacy (EC50) in a cellular context was evaluated by testing their ability to reverse the protection from cytokine withdrawal afforded by overexpression of Bcl-xL in the IL-3 dependent murine pro-B cell line FL5.12. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |